Cargando…
非小细胞肺癌中EGFR基因状态的检测对EGFR-TKIs疗效的预测价值
Epidermal growth factor receptor (EGFR) is a major molecular for target therapy. The epidermal growth factor receptor tyrosine kinase inhibitors (TKIs), gefitinib (Iressa) and erlotinib (Tarceva), are two prospective agents towards non-small cell lung cancer (NSCLC). Multi-center clinical studies sh...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000430/ https://www.ncbi.nlm.nih.gov/pubmed/20677568 http://dx.doi.org/10.3779/j.issn.1009-3419.2010.04.20 |